Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic Asthma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of HAE1 in adults with moderate to severe allergic asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma

Drugs mentioned

• HAE1

Snippet

Sponsor: Genentech, Inc. | Conditions: Allergic Asthma | Phase 2 | Status: COMPLETED